Risk factors for developing osteoporosis in diabetic kidney disease and its correlation with calcium-phosphorus metabolism, FGF23, and Klotho

被引:0
|
作者
Yang, Fan [1 ]
Wu, Yan [2 ]
Zhang, Wei [1 ]
机构
[1] Wuhu Second Peoples Hosp, Dept Endocrinol, 259 Jiuhua Middle Rd, Wuhu 241000, Anhui, Peoples R China
[2] Wuhu Second Peoples Hosp, Dept Nephrol, Wuhu 241000, Anhui, Peoples R China
关键词
Diabetic kidney disease; Osteoporosis; Calcium-phosphorus metabolism; FGF23; Klotho; COMPLICATIONS; RECEPTOR;
D O I
10.4239/wjd.v16.i1.98714
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The progression of diabetic kidney disease (DKD) affects the patient's kidney glomeruli and tubules, whose normal functioning is essential for maintaining normal calcium (Ca) and phosphorus (P) metabolism in the body. The risk of developing osteoporosis (OP) in patients with DKD increases with the aggravation of the disease, including a higher risk of fractures, which not only affects the quality of life of patients but also increases the risk of death. AIM To analyze the risk factors for the development of OP in patients with DKD and their correlation with Ca-P metabolic indices, fibroblast growth factor 23 (FGF23), and Klotho. METHODS One hundred and fifty-eight patients with DKD who were admitted into the Wuhu Second People's Hospital from September 2019 to May 2021 were selected and divided into an OP group (n = 103) and a normal bone mass group (n = 55) according to their X-ray bone densitometry results. Baseline data and differences in Ca-P biochemical indices, FGF23, and Klotho were compared. The correlation of Ca-P metabolic indices with FGF23 and Klotho was discussed, and the related factors affecting OP in patients with DKD were examined by multivariate logistic regression analysis. RESULTS The OP group had a higher proportion of females, an older age, and a longer diabetes mellitus duration than the normal group (all P < 0.05). Patients in the OP group exhibited significantly higher levels of intact parathyroid hormone (iPTH), blood P, Ca-P product (Ca x P), fractional excretion of phosphate (FeP), and FGF23, as well as lower estimated glomerular filtration rate, blood Ca, 24-hour urinary phosphate excretion (24-hour UPE), and Klotho levels (all P < 0.05). In the OP group, 25-(OH)-D3, blood Ca, and 24-hour UPE were negatively correlated with FGF23 and positively correlated with Klotho. In contrast, iPTH, blood Ca, Ca x P, and FeP exhibited a positive correlation with FGF23 and an inverse association with Klotho (all P < 0.05). Moreover, 25-(OH)-D3, iPTH, blood Ca, FePO4, FGF23, Klotho, age, and female gender were key factors that affected the lumbar and left femoral neck bone mineral density. CONCLUSION The Ca-P metabolism metabolic indexes, FGF23, and Klotho in patients with DKD are closely related to the occurrence and development of OP.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Soluble Klotho Captures FGF23 to Mitigate Aortic Valve Inflammocalcification Associated With Chronic Kidney Disease
    The, Erlinda
    Zhai, Yufeng
    Yao, Qingzhou
    Ao, Lihua
    Fullerton, David
    Meng, Xianzhong
    CIRCULATION, 2022, 146
  • [22] CALCIUM-PHOSPHORUS METABOLISM AND SERUM INTACT PTH IN PEDIATRIC CHRONIC KIDNEY DISEASE
    Jiao, Liping
    Shen, Ying
    Chen, Lu
    Liu, Xiaorong
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1611 - 1611
  • [23] Low Klotho Levels in Autosomal Dominant Polycystic Kidney Disease: Potential Mechanism of Resistance to FGF23
    Pavik, I.
    Jaeger, P.
    Kistler, A.
    Poster, D.
    Rentsch, K.
    Wuthrich, R.
    Schmid, C.
    Serra, A. L.
    SWISS MEDICAL WEEKLY, 2011, 141 : 3S - 3S
  • [24] FGF23 in Type 2 Diabetic Patients: Relationship With Bone Metabolism and Vascular Disease
    Reyes-Garcia, Rebeca
    Garcia-Martin, Antonia
    Garcia-Fontana, Beatriz
    Morales-Santana, Sonia
    Rozas-Moreno, Pedro
    Munoz-Torres, Manuel
    DIABETES CARE, 2014, 37 (05) : E89 - E90
  • [25] FGF23 adds value to risk prediction in patients with chronic kidney disease
    Smith, Edward R.
    Ford, Martin L.
    Tomlinson, Laurie A.
    McMahon, Lawrence P.
    Rajkumar, Chakravarthi
    Holt, Stephen G.
    BONE, 2012, 51 (04) : 830 - 831
  • [26] FGF23: A Review of Its Role in Mineral Metabolism and Renal and Cardiovascular Disease
    Kurpas, Anna
    Supel, Karolina
    Idzikowska, Karolina
    Zielinska, Marzenna
    DISEASE MARKERS, 2021, 2021
  • [27] Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease
    Quarles, L. Darryl
    EXPERIMENTAL CELL RESEARCH, 2012, 318 (09) : 1040 - 1048
  • [28] The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease
    Winkelmayer, WC
    Levin, R
    Avorn, J
    KIDNEY INTERNATIONAL, 2003, 63 (05) : 1836 - 1842
  • [29] CALCIUM-PHOSPHORUS METABOLISM AND PARATHYROID FUNCTION IN PATIENTS WITH END STAGE CHRONIC KIDNEY DISEASE
    Karamouzis, I.
    Thisiadou, K.
    Arampatzi, S.
    Michailidou, D.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 238 - 238
  • [30] Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages
    Tanaka, Suguru
    Fujita, Shu-ichi
    Kizawa, Shun
    Morita, Hideaki
    Ishizaka, Nobukazu
    PLOS ONE, 2016, 11 (07):